MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is often treated with doxorubicin. MicroRNAs have been shown to have important regulatory roles in cancer and serve as a target in chemoresistance. In this study, we investigated the effects of specific microRNA-200a (miR-200a) on HCC tumor cell growth and effect of do...

Full description

Bibliographic Details
Main Authors: Xiao Cui, Dachen Zhou, Qiang Du, Peiqi Wan, Kun Dong, Hui Hou, David A. Geller
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320303004

Similar Items